Oceania Healthcare Limited logo

Capital Change Notice

Capital Change29 April 2024OCAHealthcare

Capital Change Notice

Updated as at June 2023


Notice of grant of Options under the Oceania Healthcare Share Option Plan


This notice is given under the NZX Listing Rule 3.13.1. Oceania Healthcare Limited advises that

it has issued options to acquire ordinary shares in Oceania Healthcare Limited (Options) to

certain of its employees. The Options have been issued under the Oceania Healthcare Share

Option Plan.


Section 1: Issuer information

Name of issuer Oceania Healthcare Limited

NZX ticker code OCA

Class of financial product Option to acquire ordinary shares

ISIN (If unknown, check on NZX website) N/A. The Options will not be quoted.

Currency NZD

Section 2: Capital change details

Number issued 4,761,904 Options

Nominal value (if any) N/A

Issue price per security N/A

Nature of the payment (for example, cash or other

consideration)

No consideration is payable for the issue

of Options, in accordance with the

Oceania Healthcare Share Option Plan

Rules.

Amount paid up (if not in full) N/A

Percentage of total class of Financial Products

issued (calculated on the number of Financial

Products of the Class, excluding any Treasury

Stock, in existence)

1


28.57% of all Options currently on issue.


For an issue of Convertible Financial Products or

Options, the principal terms of Conversion (for

example the Conversion price and Conversion date

and the ranking of the Financial Product in relation

to other Classes of Financial Product) or the Option

(for example, the exercise price and exercise date)

Subject to continued employment, Option

holders will be able to exercise the

Options during the exercise period, which

begins 10 Business Days after

announcement of OCA’s final results in

2026 (Vesting Date) and ends 90 days

after the Vesting Date.

The exercise price for the Options is

$0.82, being the volume weighted

average price of OCA shares on the NZX

Main Board for the five-trading day period

commencing 2 days after OCA’s FY2023

results announcement (i.e. 5-day VWAP

from 26 May 2023).

On exercise of the Options, OCA will

facilitate a cashless (net settled) exercise

by issuing such number of shares as is


1

The percentage is to be calculated immediately before the issue, acquisition, redemption or Conversion.

equal to the difference between the then
current market value and the exercise

price, multiplied by the number of Options

being exercised, divided by the then

current market value.

OCA will pay tax on the Option holder’s

behalf for the taxable benefit received by

the holder under the plan, but there will be

a reduction in the number of shares to be

issued to such holder on exercise to the

extent the amount of such tax is greater

than the tax savings available to OCA (or

a subsidiary) in relation to such benefit.

Reason for issue and specific authority for issue

(the reason for change must be identified here)

The board of OCA has resolved to offer

the Options to selected employees in

order to:

(a) reward and retain key employees;

(b) drive longer-term performance and

alignment of incentives of participants with

the interests of Oceania’s shareholders;

and

(c) encourage longer term decision-

making by participants.

Total number of Financial Products of the Class

after the issue (excluding Treasury Stock) and the

total number of Financial Products of the Class held

as Treasury Stock after the issue.

21,428,571 Options

In the case of an acquisition of shares, whether

those shares are to be held as treasury stock

N/A

Specific authority for the issue, including a

reference to the rule pursuant to which the issue is

made

Board resolution dated 11 April 2024 and

NZX Listing Rule 4.6.1

Terms or details of the issue (for example:

restrictions, escrow arrangements)

Options are subject to the Oceania

Healthcare Share Option Plan Rules.

New ordinary shares issued upon

exercise of the Options will rank equally in

all respects with the ordinary shares

already on issue.

Date of issue 29/04/2024

Section 3: Authority for this announcement and contact person

Name of person


authorised to make this

announcement

Kathryn Waugh

Contact person for this announcement Kathryn Waugh

Contact phone number +64 9 361 0350

Contact email address Kathryn.Waugh@oceaniahealthcare.co.nz

Date of release through MAP


30/04/2024

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.

  • SUM — Summerset Group Holdings Limited: Notice of Allotment of Options
    2024-04-30

    Template Capital Change Notice Updated as at June 2023 Please do not amend or delete individual rows. As this template relates to prescribed content, changes to content should only be made where it is clearly indicated that this is permitted, otherwise,…”

  • RUA — Rua Bioscience Limited: Issue of shares to employees on conversion of options
    2024-06-04

    Capital Change Notice Updated as at June 2023 Section 1: Issuer information Name of issuer Rua Bioscience Limited NZX ticker code RUA Class of financial product Ordinary Shares ISIN (If unknown, check on NZX website) NZRUAE0004S1 Currency $NZ Section 2: Capital ch…”

  • BAI — Being AI: Issue of Options
    2024-05-28

    Capital Change Notice Updated as at June 2023 This notice is given under the NZX Listing Rule 3.13.1. Being AI Limited advises that it has issued options to acquire ordinary shares in Being AI Limited (Options) to certain of its employees and directors. The Optio…”